Abstract:Polycystic ovary syndrome (PCOS) is the most common heterogeneous endocrine disorder. Affecting 5%-10% 1 Li R. Zhang Q. Yang D. Li S. Lu S. Wu X. et al. Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod. 2013; 28: 2562-2569 Crossref PubMed Scopus (188) Google Scholar of reproductive-aged women, PCOS is characterized by hyperandrogenemia, anovulation, and insulin resistance (IR), with long-term effects throughout the different stages of a woman's life. During gestation, women with PCOS have greater androgen concentrations. 2 Sir-Petermann T. Maliqueo M. Angel B. Lara H.E. Perez-Bravo F. Recabarren S.E. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod. 2002; 17: 2573-2579 Crossref PubMed Google Scholar Intrauterine exposure to high androgen concentrations may cause fetal reprogramming or placental changes through epigenetic regulation or other mechanisms, thus causing changes in multiple systems in the offspring and ultimately affecting growth and development. The hormonal and metabolic alterations have been found in brothers of women with PCOS, 3 Sam S. Coviello A.D. Sung Y.A. Legro R.S. Dunaif A. Metabolic phenotype in the brothers of women with polycystic ovary syndrome. Diabetes Care. 2008; 31: 1237-1241 Crossref PubMed Scopus (45) Google Scholar ,4 Torchen L.C. Kumar A. Kalra B. Savjani G. Sisk R. Legro R.S. et al. Increased antimüllerian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome. Fertil Steril. 2016; 106: 50-55 Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar which may reflect the effects of PCOS susceptibility genes or programming effects of the intrauterine environment. Furthermore, a greater risk of pregnancy complications, 5 Palomba S. de Wilde M.A. Falbo A. Koster M.P. La Sala G.B. Fauser B.C. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015; 21: 575-592 Crossref PubMed Scopus (163) Google Scholar , 6 Damm P. Houshmand-Oeregaard A. Kelstrup L. Lauenborg J. Mathiesen E.R. Clausen T.D. Gestational diabetes mellitus and long-term consequences for mother and offspring: a view from Denmark. Diabetologia. 2016; 59: 1396-1399 Crossref PubMed Scopus (182) Google Scholar , 7 Walker C.K. Krakowiak P. Baker A. Hansen R.L. Ozonoff S. Hertz-Picciotto I. Preeclampsia, placental insufficiency, and autism spectrum disorder or developmental delay. JAMA Pediatr. 2015; 169: 154-162 Crossref PubMed Scopus (136) Google Scholar the use of metformin during pregnancy, 8 Rowan J.A. Rush E.C. Plank L.D. Lu J. Obolonkin V. Coat S. et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age. BMJ Open Diabetes Res Care. 2018; 6: e000456 Crossref PubMed Google Scholar and maternal metabolic abnormalities (including obesity or IR 9 Drake A.J. Reynolds R.M. Impact of maternal obesity on offspring obesity and cardiometabolic disease risk. Reproduction. 2010; 140: 387-398 Crossref PubMed Scopus (278) Google Scholar ,10 Fusco S. Spinelli M. Cocco S. Ripoli C. Mastrodonato A. Natale F. et al. Maternal insulin resistance multigenerationally impairs synaptic plasticity and memory via gametic mechanisms. Nat Commun. 2019; 10: 4799 Crossref PubMed Scopus (0) Google Scholar ) may be implicated in the effects on offspring.

IL-22 and Its Interaction with Amino Acid and Glycolipid Metabolite in Polycystic Ovary Syndrome (PCOS) Patients

Interleukin-22 improves ovulation in polycystic ovary syndrome via STAT3 signaling

Ovarian Leukocyte Distribution and Cytokine/chemokine Mrna Expression in Follicular Fluid Cells in Women with Polycystic Ovary Syndrome.

160.Ovarian Leukocytes and Cytokines in Polycystic Ovary Syndrome

The therapeutic effect of interleukin-22 in high androgen-induced polycystic ovary syndrome.

The Casein Kinase 2α Promotes the Occurrence Polycystic Ovary Syndrome.

Interleukin-22 promotes proliferation and reverses LPS-induced apoptosis and steroidogenesis attenuation in human ovarian granulosa cells: implications for polycystic ovary syndrome pathogenesis

Gut microbiota–bile acid–interleukin-22 axis orchestrates polycystic ovary syndrome

Interlukin-22 improves ovarian function in polycystic ovary syndrome independent of metabolic regulation: a mouse-based experimental study

Intergenerational Influences between Maternal Polycystic Ovary Syndrome and Offspring: An Updated Overview

The IL-12 family of heterodimeric cytokines in polycystic ovarian syndrome: biological role in induction, regulation, and treatment

The Relationship Between the Polymorphisms of the Luteinizing Hormone Β Subunit ( LH Β) Gly102Ser and Polycystic Ovary Syndrome

IL-18BP Therapy Ameliorates Reproductive and Metabolic Phenotypes in a PCOS Mouse Model by Relieving Inflammation, Fibrosis and Endoplasmic Reticulum Stress

IL-15 Participates in the Pathogenesis of Polycystic Ovary Syndrome by Affecting the Activity of Granulosa Cells

A Molecular and Cellular Review of the Literature

Is Interleukin-18 Associated with Polycystic Ovary Syndrome?

Untargeted Metabolomics Analysis of Serum and Follicular Fluid Samples from Women with Polycystic Ovary Syndrome.

Serum metabolomics analysis of patients with polycystic ovary syndrome by mass spectrometry

C/EBP-β and SIRT1 Regulate IL-18 Expression in the Proliferative Phase Endometrium of Patients with Polycystic Ovary Syndrome (PCOS)

Proteomics and bioinformatics analysis of follicular fluid from patients with polycystic ovary syndrome

Systemic and ovarian inflammation in women with polycystic ovary syndrome